Figure 2

Inhibition capacity of GAD65 in the RBA of 8 GADA positive sera. (A) Binding of [35S]GAD65 to 26 control human sera, (B) binding to GADA-positive sera, (C) binding to GADA-positive sera in the presence of 1 μM of Sf9-GAD65, (D) binding to GADA-positive sera in the presence of 1 μM of R. nu-GAD65, (E) binding to GADA-positive sera in the presence of 1 μM of S. frugiperda-GAD65. Binding is expressed as bound % (B%), the cut-off value is shown as a dotted line.